Impact of COVID-19 Outbreak on Female Contraceptives, Global Market Research Report 2020

June 2020 | 92 pages | ID: I7FFB6CC923DEN
QYResearch

Abstracts

The global Female Contraceptives market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Female Contraceptives volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Female Contraceptives market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Female Contraceptives market is segmented into

• Contraceptive Drugs
• Contraceptive Devices

Segment by Application

• Personal use
• Hospital

Global Female Contraceptives Market: Regional Analysis
The Female Contraceptives market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Female Contraceptives market report are:
North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Russia

Asia-Pacific

• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam

Latin America

• Mexico
• Brazil
• Argentina

Middle East & Africa

• Turkey
• Saudi Arabia
• U.A.E

Global Female Contraceptives Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Female Contraceptives market include:

• Bayer
• Mayer Laboratories
• Pfizer
• Mylan
• Teva
• Merck
• Johnson & Johnson
• Lupin Pharmaceuticals
• Female Health Company
• Fuji Latex

Contents

1 FEMALE CONTRACEPTIVES MARKET OVERVIEW

1.1 Product Overview and Scope of Female Contraceptives
1.2 Female Contraceptives Segment by Type
  1.2.1 Global Female Contraceptives Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Contraceptive Drugs
  1.2.3 Contraceptive Devices
1.3 Female Contraceptives Segment by Application
  1.3.1 Female Contraceptives Sales Comparison by Application: 2020 VS 2026
  1.3.2 Personal use
  1.3.3 Hospital
1.4 Global Female Contraceptives Market Size Estimates and Forecasts
  1.4.1 Global Female Contraceptives Revenue 2015-2026
  1.4.2 Global Female Contraceptives Sales 2015-2026
  1.4.3 Female Contraceptives Market Size by Region: 2020 Versus 2026

2 GLOBAL FEMALE CONTRACEPTIVES MARKET COMPETITION BY MANUFACTURERS

2.1 Global Female Contraceptives Sales Market Share by Manufacturers (2015-2020)
2.2 Global Female Contraceptives Revenue Share by Manufacturers (2015-2020)
2.3 Global Female Contraceptives Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Female Contraceptives Manufacturing Sites, Area Served, Product Type
2.5 Female Contraceptives Market Competitive Situation and Trends
  2.5.1 Female Contraceptives Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Female Contraceptives Players (Opinion Leaders)

3 FEMALE CONTRACEPTIVES RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Female Contraceptives Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Female Contraceptives Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Female Contraceptives Market Facts & Figures by Country
  3.3.1 North America Female Contraceptives Sales by Country
  3.3.2 North America Female Contraceptives Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Female Contraceptives Market Facts & Figures by Country
  3.4.1 Europe Female Contraceptives Sales by Country
  3.4.2 Europe Female Contraceptives Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Female Contraceptives Market Facts & Figures by Region
  3.5.1 Asia Pacific Female Contraceptives Sales by Region
  3.5.2 Asia Pacific Female Contraceptives Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Female Contraceptives Market Facts & Figures by Country
  3.6.1 Latin America Female Contraceptives Sales by Country
  3.6.2 Latin America Female Contraceptives Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Female Contraceptives Market Facts & Figures by Country
  3.7.1 Middle East and Africa Female Contraceptives Sales by Country
  3.7.2 Middle East and Africa Female Contraceptives Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 U.A.E

4 GLOBAL FEMALE CONTRACEPTIVES HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Female Contraceptives Sales Market Share by Type (2015-2020)
4.2 Global Female Contraceptives Revenue Market Share by Type (2015-2020)
4.3 Global Female Contraceptives Price Market Share by Type (2015-2020)
4.4 Global Female Contraceptives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 GLOBAL FEMALE CONTRACEPTIVES HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Female Contraceptives Sales Market Share by Application (2015-2020)
5.2 Global Female Contraceptives Revenue Market Share by Application (2015-2020)
5.3 Global Female Contraceptives Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN FEMALE CONTRACEPTIVES BUSINESS

6.1 Bayer
  6.1.1 Corporation Information
  6.1.2 Bayer Description, Business Overview and Total Revenue
  6.1.3 Bayer Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 Bayer Products Offered
  6.1.5 Bayer Recent Development
6.2 Mayer Laboratories
  6.2.1 Mayer Laboratories Female Contraceptives Production Sites and Area Served
  6.2.2 Mayer Laboratories Description, Business Overview and Total Revenue
  6.2.3 Mayer Laboratories Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 Mayer Laboratories Products Offered
  6.2.5 Mayer Laboratories Recent Development
6.3 Pfizer
  6.3.1 Pfizer Female Contraceptives Production Sites and Area Served
  6.3.2 Pfizer Description, Business Overview and Total Revenue
  6.3.3 Pfizer Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 Pfizer Products Offered
  6.3.5 Pfizer Recent Development
6.4 Mylan
  6.4.1 Mylan Female Contraceptives Production Sites and Area Served
  6.4.2 Mylan Description, Business Overview and Total Revenue
  6.4.3 Mylan Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Mylan Products Offered
  6.4.5 Mylan Recent Development
6.5 Teva
  6.5.1 Teva Female Contraceptives Production Sites and Area Served
  6.5.2 Teva Description, Business Overview and Total Revenue
  6.5.3 Teva Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Teva Products Offered
  6.5.5 Teva Recent Development
6.6 Merck
  6.6.1 Merck Female Contraceptives Production Sites and Area Served
  6.6.2 Merck Description, Business Overview and Total Revenue
  6.6.3 Merck Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Merck Products Offered
  6.6.5 Merck Recent Development
6.7 Johnson & Johnson
  6.6.1 Johnson & Johnson Female Contraceptives Production Sites and Area Served
  6.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
  6.6.3 Johnson & Johnson Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Johnson & Johnson Products Offered
  6.7.5 Johnson & Johnson Recent Development
6.8 Lupin Pharmaceuticals
  6.8.1 Lupin Pharmaceuticals Female Contraceptives Production Sites and Area Served
  6.8.2 Lupin Pharmaceuticals Description, Business Overview and Total Revenue
  6.8.3 Lupin Pharmaceuticals Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 Lupin Pharmaceuticals Products Offered
  6.8.5 Lupin Pharmaceuticals Recent Development
6.9 Female Health Company
  6.9.1 Female Health Company Female Contraceptives Production Sites and Area Served
  6.9.2 Female Health Company Description, Business Overview and Total Revenue
  6.9.3 Female Health Company Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.9.4 Female Health Company Products Offered
  6.9.5 Female Health Company Recent Development
6.10 Fuji Latex
  6.10.1 Fuji Latex Female Contraceptives Production Sites and Area Served
  6.10.2 Fuji Latex Description, Business Overview and Total Revenue
  6.10.3 Fuji Latex Female Contraceptives Sales, Revenue and Gross Margin (2015-2020)
  6.10.4 Fuji Latex Products Offered
  6.10.5 Fuji Latex Recent Development

7 FEMALE CONTRACEPTIVES MANUFACTURING COST ANALYSIS

7.1 Female Contraceptives Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Female Contraceptives
7.4 Female Contraceptives Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Female Contraceptives Distributors List
8.3 Female Contraceptives Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Female Contraceptives Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Female Contraceptives by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Female Contraceptives by Type (2021-2026)
10.2 Female Contraceptives Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Female Contraceptives by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Female Contraceptives by Application (2021-2026)
10.3 Female Contraceptives Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Female Contraceptives by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Female Contraceptives by Region (2021-2026)
10.4 North America Female Contraceptives Estimates and Projections (2021-2026)
10.5 Europe Female Contraceptives Estimates and Projections (2021-2026)
10.6 Asia Pacific Female Contraceptives Estimates and Projections (2021-2026)
10.7 Latin America Female Contraceptives Estimates and Projections (2021-2026)
10.8 Middle East and Africa Female Contraceptives Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Female Contraceptives Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Female Contraceptives Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Female Contraceptives Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Female Contraceptives Manufacturers Covered in This Study
Table 5. Global Female Contraceptives Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Female Contraceptives Sales Share by Manufacturers (2015-2020)
Table 7. Global Female Contraceptives Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Female Contraceptives Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Female Contraceptives Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Female Contraceptives Sales Sites and Area Served
Table 11. Manufacturers Female Contraceptives Product Types
Table 12. Global Female Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Female Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Contraceptives as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Female Contraceptives Players
Table 16. Global Female Contraceptives Sales (K Units) by Region (2015-2020)
Table 17. Global Female Contraceptives Sales Market Share by Region (2015-2020)
Table 18. Global Female Contraceptives Revenue (Million US$) by Region (2015-2020)
Table 19. Global Female Contraceptives Revenue Market Share by Region (2015-2020)
Table 20. North America Female Contraceptives Sales by Country (2015-2020) (K Units)
Table 21. North America Female Contraceptives Sales Market Share by Country (2015-2020)
Table 22. North America Female Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Female Contraceptives Revenue Market Share by Country (2015-2020)
Table 24. Europe Female Contraceptives Sales by Country (2015-2020) (K Units)
Table 25. Europe Female Contraceptives Sales Market Share by Country (2015-2020)
Table 26. Europe Female Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Female Contraceptives Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Female Contraceptives Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Female Contraceptives Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Female Contraceptives Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Female Contraceptives Revenue Market Share by Region (2015-2020)
Table 32. Latin America Female Contraceptives Sales by Country (2015-2020) (K Units)
Table 33. Latin America Female Contraceptives Sales Market Share by Country (2015-2020)
Table 34. Latin America Female Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Female Contraceptives Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Female Contraceptives Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Female Contraceptives Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Female Contraceptives Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Female Contraceptives Revenue Market Share by Country (2015-2020)
Table 40. Global Female Contraceptives Sales (K Units) by Type (2015-2020)
Table 41. Global Female Contraceptives Sales Share by Type (2015-2020)
Table 42. Global Female Contraceptives Revenue (Million US$) by Type (2015-2020)
Table 43. Global Female Contraceptives Revenue Share by Type (2015-2020)
Table 44. Global Female Contraceptives Price (USD/Unit) by Type (2015-2020)
Table 45. Global Female Contraceptives Sales (K Units) by Application (2015-2020)
Table 46. Global Female Contraceptives Sales Market Share by Application (2015-2020)
Table 47. Global Female Contraceptives Sales Growth Rate by Application (2015-2020)
Table 48. Bayer Female Contraceptives Corporation Information
Table 49. Bayer Description and Business Overview
Table 50. Bayer Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Bayer Main Product
Table 52. Bayer Recent Development
Table 53. Mayer Laboratories Female Contraceptives Corporation Information
Table 54. Mayer Laboratories Corporation Information
Table 55. Mayer Laboratories Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Mayer Laboratories Main Product
Table 57. Mayer Laboratories Recent Development
Table 58. Pfizer Female Contraceptives Corporation Information
Table 59. Pfizer Corporation Information
Table 60. Pfizer Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Pfizer Main Product
Table 62. Pfizer Recent Development
Table 63. Mylan Female Contraceptives Corporation Information
Table 64. Mylan Corporation Information
Table 65. Mylan Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Mylan Main Product
Table 67. Mylan Recent Development
Table 68. Teva Female Contraceptives Corporation Information
Table 69. Teva Corporation Information
Table 70. Teva Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Teva Main Product
Table 72. Teva Recent Development
Table 73. Merck Female Contraceptives Corporation Information
Table 74. Merck Corporation Information
Table 75. Merck Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Merck Main Product
Table 77. Merck Recent Development
Table 78. Johnson & Johnson Female Contraceptives Corporation Information
Table 79. Johnson & Johnson Corporation Information
Table 80. Johnson & Johnson Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Johnson & Johnson Main Product
Table 82. Johnson & Johnson Recent Development
Table 83. Lupin Pharmaceuticals Female Contraceptives Corporation Information
Table 84. Lupin Pharmaceuticals Corporation Information
Table 85. Lupin Pharmaceuticals Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Lupin Pharmaceuticals Main Product
Table 87. Lupin Pharmaceuticals Recent Development
Table 88. Female Health Company Female Contraceptives Corporation Information
Table 89. Female Health Company Corporation Information
Table 90. Female Health Company Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Female Health Company Main Product
Table 92. Female Health Company Recent Development
Table 93. Fuji Latex Female Contraceptives Corporation Information
Table 94. Fuji Latex Corporation Information
Table 95. Fuji Latex Female Contraceptives Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Fuji Latex Main Product
Table 97. Fuji Latex Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Female Contraceptives Distributors List
Table 101. Female Contraceptives Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Female Contraceptives Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Female Contraceptives Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Female Contraceptives Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Female Contraceptives Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Female Contraceptives Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Female Contraceptives Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Female Contraceptives Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Female Contraceptives Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Female Contraceptives Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Female Contraceptives Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Female Contraceptives
Figure 2. Global Female Contraceptives Sales Market Share by Type: 2020 VS 2026
Figure 3. Contraceptive Drugs Product Picture
Figure 4. Contraceptive Devices Product Picture
Figure 5. Global Female Contraceptives Consumption Market Share by Application: 2020 VS 2026
Figure 6. Personal use
Figure 7. Hospital
Figure 8. Global Female Contraceptives Market Size 2015-2026 (US$ Million)
Figure 9. Global Female Contraceptives Sales Capacity (K Units) (2015-2026)
Figure 10. Global Female Contraceptives Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Female Contraceptives Sales Share by Manufacturers in 2020
Figure 12. Global Female Contraceptives Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Female Contraceptives Revenue in 2019
Figure 14. Female Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Female Contraceptives Sales Market Share by Region (2015-2020)
Figure 16. Global Female Contraceptives Sales Market Share by Region in 2019
Figure 17. Global Female Contraceptives Revenue Market Share by Region (2015-2020)
Figure 18. Global Female Contraceptives Revenue Market Share by Region in 2019
Figure 19. North America Female Contraceptives Sales Market Share by Country in 2019
Figure 20. North America Female Contraceptives Revenue Market Share by Country in 2019
Figure 21. U.S. Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 22. U.S. Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 24. Canada Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe Female Contraceptives Sales Market Share by Country in 2019
Figure 26. Europe Female Contraceptives Revenue Market Share by Country in 2019
Figure 27. Germany Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 28. Germany Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 32. U.K. Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 34. Italy Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 36. Russia Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific Female Contraceptives Sales Market Share by Region in 2019
Figure 38. Asia Pacific Female Contraceptives Revenue Market Share by Region in 2019
Figure 39. China Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 40. China Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 42. Japan Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 44. South Korea Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 46. India Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 48. Australia Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 52. Indonesia Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 54. Thailand Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 56. Malaysia Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 58. Philippines Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 60. Vietnam Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America Female Contraceptives Sales Market Share by Country in 2019
Figure 62. Latin America Female Contraceptives Revenue Market Share by Country in 2019
Figure 63. Mexico Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 64. Mexico Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 66. Brazil Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 68. Argentina Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa Female Contraceptives Sales Market Share by Country in 2019
Figure 70. Middle East and Africa Female Contraceptives Revenue Market Share by Country in 2019
Figure 71. Turkey Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 72. Turkey Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 74. Saudi Arabia Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. U.A.E Female Contraceptives Sales Growth Rate (2015-2020) (K Units)
Figure 76. U.A.E Female Contraceptives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of Female Contraceptives by Type (2015-2020)
Figure 78. Sales Market Share of Female Contraceptives by Type in 2019
Figure 79. Revenue Share of Female Contraceptives by Type (2015-2020)
Figure 80. Revenue Market Share of Female Contraceptives by Type in 2019
Figure 81. Global Female Contraceptives Sales Growth by Type (2015-2020) (K Units)
Figure 82. Global Female Contraceptives Sales Market Share by Application (2015-2020)
Figure 83. Global Female Contraceptives Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of Female Contraceptives by Application (2015-2020)
Figure 85. Global Revenue Share of Female Contraceptives by Application in 2020
Figure 86. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Mayer Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Female Health Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Fuji Latex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of Female Contraceptives
Figure 98. Manufacturing Process Analysis of Female Contraceptives
Figure 99. Female Contraceptives Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America Female Contraceptives Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. North America Female Contraceptives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe Female Contraceptives Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Female Contraceptives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America Female Contraceptives Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Female Contraceptives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa Female Contraceptives Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Female Contraceptives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific Female Contraceptives Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Female Contraceptives Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed